Top

Antimicrobial Resistance & Infection Control

Published in:

Open Access 01-12-2017 | Review

The threat of antimicrobial resistance in developing countries: causes and control strategies

Authors: James A. Ayukekbong, Michel Ntemgwa, Andrew N. Atabe

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2017

Abstract

The causes of antimicrobial resistance (AMR) in developing countries are complex and may be rooted in practices of health care professionals and patients’ behavior towards the use of antimicrobials as well as supply chains of antimicrobials in the population. Some of these factors may include inappropriate prescription practices, inadequate patient education, limited diagnostic facilities, unauthorized sale of antimicrobials, lack of appropriate functioning drug regulatory mechanisms, and non-human use of antimicrobials such as in animal production. Considering that these factors in developing countries may vary from those in developed countries, intervention efforts in developing countries need to address the context and focus on the root causes specific to this part of the world. Here, we describe these health-seeking behaviors that lead to the threat of AMR and healthcare practices that drive the development of AMR in developing countries and we discuss alternatives for disease prevention as well as other treatment options worth exploring.

Byarugaba DK. A view on antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004;24:105–10.CrossRefPubMed

Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13:1057–98.CrossRefPubMed

Okeke IN, Klugman KP, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect. Dis. 2005;5:568–80.

Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect. Dis. 2005;5:481–93.

Hart CA, Kariuki S. Antimicrobial resistance in developing countries. BMJ. 1998;317:647–50.CrossRefPubMedPubMedCentral

Okeke IN, Lamikanra A, Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis. 1999;5:18–27.CrossRefPubMedPubMedCentral

Kunin CM. Resistance to antimicrobial drugs--a worldwide calamity. Ann Intern Med. 1993;118:557–61.CrossRefPubMed

Fluit AC, Visser MR, Schmitz FJ. Molecular detection of antimicrobial resistance. Clin Microbiol Rev. 2001;14:836–871, table of contents.

Kohanski MA, Dwyer DJ, Collins JJ. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol. 2010;8:423–35.CrossRefPubMedPubMedCentral

10.

Roberts MC. Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol Rev. 1996;19:1–24.CrossRefPubMed

11.

Quick J, Bremer K. Quality control of essential drugs. Lancet Lond Engl. 1997;350:1106.CrossRef

12.

Lansang MA, Lucas-Aquino R, Tupasi TE, Mina VS, Salazar LS, Juban N, Limjoco TT, Nisperos LE, Kunin CM. Purchase of antibiotics without prescription in Manalia, the Philippines. Inappropriate choices and doses. J Clin Epidemiol. 1990;43:61–7.

13.

Okeke IN, Aboderin OA, Byarugaba DK, Ojo KK, Opintan JA. Growing problem of multidrug-resistant enteric pathogens in Africa. Emerg Infect Dis. 2007;13:1640–6.CrossRefPubMedPubMedCentral

14.

Goel P, Ross-Degnan D, Berman P, Soumerai S. Retail pharmacies in developing countries: a behavior and intervention framework. Soc Sci Med. 1996;42:1155–61.CrossRefPubMed

15.

Kwena Z, Sharma A, Wamae N, Muga C, Bukusi E. Provider characteristics among staff providing care to sexually transmitted infection self-medicating patients in retail pharmacies in Kibera slum, Nairobi. Kenya Sex Transm Dis. 2008;35:480–3.CrossRefPubMed

16.

Basco LK. Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. AmJTrop Med Hyg. 2004;70:245–50.

17.

Winstanley P, Ward S, Snow R, Breckenridge A. Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy. Clin Microbiol Rev. 2004;17:612–37.CrossRefPubMedPubMedCentral

18.

Okeke IN, Lamikanra A. Quality and bioavailability of ampicillin capsules dispensed in a Nigerian semi-urban community. Afr J Med Med Sci. 2001;30:47–51.PubMed

19.

Risha PG, Shewiyo D, Msami A, Masuki G, Vergote G, Vervaet C, et al. In vitro evaluation of the quality of essential drugs on the Tanzanian market. Trop Med Int Health TM IH. 2002;7:701–7.CrossRefPubMed

20.

Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med. 2005;2:e100.CrossRefPubMedPubMedCentral

21.

Kelesidis T, Kelesidis I, Rafailidis PI, Falagas ME. Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. J Antimicrob Chemother. 2007;60:214–36.CrossRefPubMed

22.

Usluer G, Ozgunes I, Leblebicioglu H, Turkish antibiotic utilization study group. A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob. 2005;4:16.CrossRefPubMedPubMedCentral

23.

Saleh N, Awada S, Awwad R, Jibai S, Arfoul C, Zaiter L, et al. Evaluation of antibiotic prescription in the Lebanese community: a pilot study. Infect Ecol Epidemiol. 2015;5:27094.CrossRefPubMed

24.

Neu HC. The crisis in antibiotic resistance. Science. 1992;257:1064–73.CrossRefPubMed

25.

Calva J, Bojalil R. Antibiotic use in a periurban community in Mexico: a household and drugstore survey. Soc Sci Med. 1996;42:1121–8.CrossRefPubMed

26.

Reynolds L, McKee M. Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy. 2009;90:32–6.CrossRefPubMed

27.

Malfertheiner P. Compliance, adverse events and antibiotic resistance in helicobacter pylori treatment. Scand J Gastroenterol. 1993;28:34–7.CrossRef

28.

Collignon P, Wegener HC, Braam P, Butler CD. The routine use of antibiotics to promote animal growth does little to benefit protein undernutrition in the developing world. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc Am. 2005;41:1007–13.CrossRef

29.

Petersen A, Andersen JS, Kaewmak T, Somsiri T, Dalsgaard A. Impact of integrated fish farming on antimicrobial resistance in a pond environment. Appl Environ Microbiol. 2002;68:6036–42.CrossRefPubMedPubMedCentral

30.

Vidaver AK. Uses of antimicrobials in plant agriculture. Clin Infect Dis Off Publ Infect Dis Soc Am. 2002;34(Suppl 3):S107–10.CrossRef

31.

Witte W. Medical consequences of antibiotic use in agriculture. Science. 1998;279:996–7.CrossRefPubMed

32.

Food and Agriculture Organization. Drivers, dynamics and epidemiology of antimicrobial resistance in animal production. [Internet]. FAO; 2016 [cited 2017 Jan 4]. Available from: http://www.fao.org/3/a-i6209e.pdf

33.

Aarestrup F. Sustainable farming: get pigs off antibiotics. Nature. 2012;486:465–6.CrossRefPubMed

34.

Mitema ES, Kikuvi GM, Wegener HC, Stohr K. An assessment of antimicrobial consumption in food producing animals in Kenya. J Vet Pharmacol Ther. 2001;24:385–90.CrossRefPubMed

35.

Mezali L, Hamdi TM. Prevalence and antimicrobial resistance of Salmonella isolated from meat and meat products in Algiers (Algeria). Foodborne Pathog Dis. 2012;9:522–9.CrossRefPubMed

36.

Addis Z, Kebede N, Sisay Z, Alemayehu H, Wubetie A, Kassa T. Prevalence and antimicrobial resistance of Salmonella isolated from lactating cows and in contact humans in dairy farms of Addis Ababa: a cross sectional study. BMC Infect. Dis. [Internet]. 2011 [cited 2017 Jan 24];11. Available from: http://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-11-222.

37.

Fortini D, Fashae K, García-Fernández A, Villa L, Carattoli A. Plasmid-mediated quinolone resistance and β-lactamases in Escherichia coli from healthy animals from Nigeria. J Antimicrob Chemother. 2011;66:1269–72.CrossRefPubMed

38.

Kikuvi GM, Ombui JN, Mitema ES. Serotypes and antimicrobial resistance profiles of Salmonella isolates from pigs at slaughter in Kenya. J Infect Dev Ctries. 2010;4:243–8.CrossRefPubMed

39.

Doyle ME. Multidrug-resistant pathogens in the food supply. Foodborne Pathog Dis. 2015;12:261–79.CrossRefPubMed

40.

Simango C, Rukure G. Potential sources of campylobacter species in the homes of farmworkers in Zimbabwe. J Trop Med Hyg. 1991;94:388–92.PubMed

41.

Roess AA, Winch PJ, Akhter A, Afroz D, Ali NA, Shah R, et al. Household animal and human medicine use and animal husbandry practices in rural Bangladesh: risk factors for emerging Zoonotic disease and antibiotic resistance. Zoonoses Public Health. 2015;62:569–78.CrossRefPubMedPubMedCentral

42.

Cabello FC. Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environ Microbiol. 2006;8:1137–44.CrossRefPubMed

43.

Brandenburg K, Schürholz T. Lack of new antiinfective agents: passing into the pre-antibiotic age? World J Biol Chem. 2015;6:71–7.CrossRefPubMedPubMedCentral

44.

Smith MA, Garbharran H, Edwards MJ, O’Hara-Murdock P. Health promotion and disease prevention through sanitation education in south African Zulu and Xhosa women. J Transcult Nurs Off J Transcult Nurs Soc. 2004;15:62–8.CrossRef

45.

Hinman AR, Orenstein WA. Adult immunization: what can we learn from the childhood immunization program? Clin Infect Dis Off Publ Infect Dis Soc Am. 2007;44:1532–5.CrossRef

46.

Iglehart JK. Health policy report. The centers for disease control. N Engl J Med. 1983;308:604–8.CrossRefPubMed

47.

Robinson CA, Bart KJ. Disease prevention through immunization: the beginning of health care reform. Public Health Rep. 1993;108:417–8.PubMedPubMedCentral

48.

van Panhuis WG, Grefenstette J, Jung SY, Chok NS, Cross A, Eng H, et al. Contagious diseases in the United States from 1888 to the present. N Engl J Med. 2013;369:2152–8.CrossRefPubMedPubMedCentral

49.

López EL, Glatstein E, Ezcurra GC, Iacono M, Teplitz E, Garnero AV, et al. Rapid Decrease in Rates of Hospitalization Resulting From Invasive Pneumococcal Disease and Community-Acquired Pneumonia in Children Aged <60 Months After 13-Valent Pneumococcal Conjugate Vaccine Introduction in Argentina. J Pediatr Infect Dis Soc. 2017. doi:10.1093/jpids/piw089.

50.

Barrow PA, Soothill JS. Bacteriophage therapy and prophylaxis: rediscovery and renewed assessment of potential. Trends Microbiol. 1997;5:268–71.CrossRefPubMed

51.

Alisky J, Iczkowski K, Rapoport A, Troitsky N. Bacteriophages show promise as antimicrobial agents. J Inf Secur. 1998;36:5–15.

52.

Mathur MD, Vidhani S, Mehndiratta PL. Bacteriophage therapy: an alternative to conventional antibiotics. J Assoc Physicians India. 2003;51:593–6.PubMed

53.

Rasmussen TB, Givskov M. Quorum-sensing inhibitors as anti-pathogenic drugs. Int J Med Microbiol IJMM. 2006;296:149–61.CrossRefPubMed

54.

Williams P. Quorum sensing, communication and cross-kingdom signalling in the bacterial world. Microbiol Read Engl. 2007;153:3923–38.CrossRef

55.

Waters CM, Bassler BL. Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol. 2005;21:319–46.CrossRefPubMed

56.

Brandt LJ. Fecal transplantation for the treatment of Clostridium Difficile infection. Gastroenterol Hepatol. 2012;8:191–4.

57.

Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology. 2009;136:2015–31.CrossRefPubMedPubMedCentral

58.

Vrieze A, de Groot PF, Kootte RS, Knaapen M, van Nood E, Nieuwdorp M. Fecal transplant: a safe and sustainable clinical therapy for restoring intestinal microbial balance in human disease? Best Pract Res Clin Gastroenterol. 2013;27:127–37.CrossRefPubMed

59.

Borody TJ, Brandt LJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: a new standard treatment option for Clostridium Difficile infection. Expert Rev Anti-Infect Ther. 2013;11:447–9.CrossRefPubMed

60.

Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep. 2013;15:337.CrossRefPubMedPubMedCentral

61.

Bhutta TI, Balchin C. Assessing the impact of a regulatory intervention in Pakistan. Soc Sci Med. 1996;42:1195–202.CrossRefPubMed

62.

Blakely JT-M, Sinkowitz-Cochran RL, Jarvis WR. Infectious diseases physicians’ preferences for continuing medical education on antimicrobial resistance and other general topics. Infect Control Hosp Epidemiol. 2006;27:873–5.CrossRefPubMed

63.

Martinez-Cajas JL, Invernizzi CF, Ntemgwa M, Schader SM, Wainberg MA. Benefits of an educational program for journalists on media coverage of HIV/AIDS in developing countries. J Int AIDS Soc. 2008;11:2.CrossRefPubMedPubMedCentral

64.

Martinez-Cajas JL, Invernizzi CF, Ntemgwa M, Schader SM, Wainberg MA. The impact of the journalist-to-journalist program on worldwide HIV awareness. AIDS Lond Engl. 2008;22:1687–8.CrossRef

65.

World Health Organization. Global action plan on antimicrobial resistance [Internet]. 2015 [cited 2017 Jan 4]. Available from: http://apps.who.int/iris/bitstream/10665/193736/1/9789241509763_eng.pdf?ua=1.

66.

Government of Canada. Federal action plan on antimicrobial resistance and use in Canada (building on the federal framework for action). Accessed [Internet]. 2015 [cited 2017 Jan 4]. Available from: http://healthycanadians.gc.ca/alt/pdf/publications/drugs-products-medicaments-produits/antibiotic-resistance-antibiotique/action-plan-daction-eng.pdf.

67.

Government of the United Kingdom. UK Five Year Antimicrobial Resistance Strategy 2013 to 2018 [Internet]. 2013 [cited 2017 Jan 4]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf.

68.

Government of the United States. National strategy for combating antibiotic-resistant bacteria. [Internet]. 2015 [cited 2017 Jan 4]. Available from: https://www.cdc.gov/drugresistance/pdf/national_action_plan_for_combating_antibotic-resistant_bacteria.pdf.

69.

World Health Organization. WHO report finds systems to combat antibiotic resistance lacking [Internet]. 2015 [cited 2017 Jan 4]. Available from: http://www.who.int/mediacentre/news/releases/2015/antibiotic-resistance-lacking/en/.

70.

World Health Organization. Additional global, regional and national strategies and plans to address antimicrobial resistance [Internet]. 2014 [cited 2016 Dec 3]. Available from: http://www.cddep.org/garp/home.

71.

Africa Society for Laboratory Medicine. ASLM2016 helps to answer United Nations call to tackle threat of antimicrobial resistance. [Internet]. 2016 [cited 2017 Jan 4]. Available from: http://aslm2016.org/aslm2016-helps-to-answer-united-nations-call-to-tackle-threat-of-antimicrobial-resistance/.

72.

Tollefson L. Developing new regulatory approaches to antimicrobial safety. J Vet Med B Infect Dis Vet Public Health. 2004;51:415–8.CrossRefPubMed

73.

WHO. Global action plan on antimicrobial resistance. 2015 [cited 2017 Jan 5]; Available from: http://apps.who.int/iris/bitstream/10665/193736/1/9789241509763_eng.pdf?ua=1.

74.

WHO. Additional global, regional and national strategies and plans to address antimicrobial resistance. 2014 [cited 2016 Dec 4]; Available from: http://www.who.int/drugresistance/global_action_plan/General_and_national_plans_amr_Dec_2014.pdf.

75.

Dua V, Kunin CM, White LV. The use of antimicrobial drugs in Nagpur, India. A window on medical care in a developing country. Soc Sci Med. 1994;38:717–24.CrossRefPubMed

76.

NEPAD. African Medicines Regulatory Harmonization (AMRH). 2016 [cited 2017 Jan 5]; Available from: http://www.nepad.org/content/african-medicines-regulatory-harmonisation-armh-programs?qt-programme_page=1.

Title: The threat of antimicrobial resistance in developing countries: causes and control strategies
Authors: James A. Ayukekbong
Michel Ntemgwa
Andrew N. Atabe
Publication date: 01-12-2017
Publisher: BioMed Central
Published in: Antimicrobial Resistance & Infection Control / Issue 1/2017
Electronic ISSN: 2047-2994
DOI: https://doi.org/10.1186/s13756-017-0208-x

Genetic characterization of novel class 1 Integrons In0, In1069 and In1287 to In1290, and the inference of In1069-associated integron evolution in Enterobacteriaceae

Open Access
Research

Prospective surveillance of healthcare associated infections in a Cambodian pediatric hospital

Open Access
Research

Readiness for antimicrobial resistance (AMR) surveillance in Pakistan; a model for laboratory strengthening

Open Access
Research

Virulence traits associated with Burkholderia cenocepacia ST856 epidemic strain isolated from cystic fibrosis patients

Open Access
Research

Patient engagement with surgical site infection prevention: an expert panel perspective

Open Access
Review

P. aeruginosa colonization at ICU admission as a risk factor for developing P. aeruginosa ICU pneumonia

Open Access
Short report

Keynote webinar | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Watch now

Keynote webinar | Spotlight on adolescent vaping

Live
Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET

Prof. Ann McNeill

Dr. Debbie Robson

Benji Horwell

Developed by: Springer Medicine

Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty in Geriatric Patients
On-demand webinar

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft

Prof. Barbara C. van Munster

Prof. Mirko Petrovic

Developed by: Springer Medicine

Watch now

A quick guide to ECGs

Electrocardiography
Training Course

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date.

PD Dr. Carsten W. Israel

Developed by: Springer Medizin

Start the cases

At a glance: The STEP trials

Obesity
Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on adolescent vaping

Springer Medicine

Abstract

Please log in to get access to this content